Flagship explainer
How TEVA PHARMACEUTICAL INDUSTRIES LIMITED makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $17.3B | 100% |
| |
| Cost of revenue | $8.3B | 48% |
|
| $8.9B | 52% |
| |
| $2.2B | 12% |
| |
| Income before tax | $1.2B | 7% |
|
| Income tax | −$180M | −1% |
|
| $1.4B | 8% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-034532